Aduhelm

Why The FDA's Approval Of A New Alzheimer's Drug Should Worry You

Aduhelm, a pricey treatment meant to stall mental decline, may be a case study in everything that's wrong with how America manages prescription drugs.
ByĀ 

FDA Adviser Quits Over 'Probably The Worst' Approval Decision Of Alzheimer's Drug

The controversial drug, called Aduhelm, costs $56,000 a year and some patients could face copayments of $11,500 annually.
By RICARDO ALONSO-ZALDIVAR and MATTHEW PERRONE, AP